Showing 3721-3730 of 5849 results for "".
- Dermavant Publishes ADORING 1 & ADORING 2 Phase 3 Trial Results for Vtama Cream for ADhttps://practicaldermatology.com/news/dermavant-publishes-adoring-1-adoring-2-phase-3-trial-results-vtama-cream-ad/2463173/Dermavant Sciences announced that the data from ADORING 1 and ADORING 2 phase 3 trials of Vtama (tapinarof) cream 1% for adults and children 2 years of age and older with atopic dermatitis (AD) has been published in the Journal of the American Academy of Dermatology. Vtama cream i
- Alma Unveils Versatile Aesthetic Workstation and Smart Skin Analysis Systemhttps://practicaldermatology.com/news/alma-unveils-versatile-aesthetic-workstation-and-smart-skin-analysis-system/2463172/Energy-based device manufacturer Alma has introduced Alma Harmony and Alma IQ. Alma Harmony is the latest version of the company's multi-technology aesthetics workstation and is available for sale in the U.S. This system, according to a press release, builds on a 20-year legacy and is FDA
- Antihypertensive Drugs Linked to Increased Eczema in Elderlyhttps://practicaldermatology.com/news/antihypertensive-drugs-linked-increased-eczema-elderly/2463140/New research suggests that increased use of antihypertensive medications is associated with an increase in eczematous dermatitis. Researchers conducted a longitudinal cohort study in a population-based sample from primary care practices in The Health Improvement Network in the United Kingd
- World Congress for Hair Research Convenes in Texashttps://practicaldermatology.com/news/world-congress-hair-research-convenes-texas/2463139/Hundreds of internationally renowned scientists and clinicians interested in hair research gathered in Dallas, Texas, from April 6-9, for the 13th World Congress for Hair Research. Hosted by the American Hair Research Society (AHRS), a member of the International Federation of Hair Res
- A New, Proactive Approach to Newborn Skincarehttps://practicaldermatology.com/news/new-proactive-approach-newborn-skincare/2463138/Aveeno Baby announced the launch of Healthy Start, a proactive approach to newborn skincare featuring a wash and balm duo that are safe to use on newborn skin from birth. Aveeno Baby Healthy Start Newborn Wash is a nourishing cleanser made with prebiotic oat, oat extract, and glycerin to
- Reflections on the “Clearly Me” Psoriasis Exhibithttps://practicaldermatology.com/news/reflecting-on-clearly-me-psoriasis-exhibit-a-qa-with-lindsay-adler/2463137/The “Clearly Me” exhibit in New York, New York, held from May 16-18, showcased real psoriatic patients through dynamic photographic portraits, captured by photographer L
- Research IDs New Psoriasis Inflammation Pathwayhttps://practicaldermatology.com/news/research-ids-new-psoriasis-inflammation-pathway/2463125/Researchers from a recent study have identified a key biological pathway responsible for the inflammation seen in psoriasis, with potential implications for other inflammatory diseases like atopic dermatitis, allergic dermatitis, and hidradenitis suppurativa. The study, published in the j
- International Cosmetic Surgery Patients Report Higher Seroma and Antibiotic Usehttps://practicaldermatology.com/news/international-cosmetic-surgery-patients-report-higher-seroma-and-antibiotic-use/2463111/International cosmetic surgery was associated with higher rates of antibiotic use and seroma formation, according to results from a new analysis. Researchers
- Survey Shows Variability in Hyaluronidase Use Among Practitionershttps://practicaldermatology.com/news/survey-shows-variability-hyaluronidase-use-among-practitioners/2463109/New research suggests there are inconsistencies in the use of hyaluronidase (HYAL) for the treatment of adverse events with hyaluronic acid (HA) fillers, suggesting a need for standardized guidelines. "With the growing popularity and administration of HA fillers, there is likely to be a c
- Pilot Study Supports Once-Daily Isotretinoin for Acne Treatmenthttps://practicaldermatology.com/news/pilot-study-supports-once-daily-isotretinoin-acne-treatment/2463088/Micronized isotretinoin administered once per day without food was effective and well-tolerated for the treatment of severe nodular acne, new study results indicate. Researchers for the pilot study focused on and evaluated a regimen of once-daily micronized isotretinoin (0.4 to 0.8 mg/kg/